UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 104

Sortiert nach

sup 99m^Tc-3PRGD^sub 2^ for Integrin Receptor Imaging of Esophageal Cancer, Compared Study with ^sup 18^F-FDG PET/CT

The Journal of nuclear medicine (1978), 2018-05, Vol.59, p.1409

2018

Volltextzugriff (PDF)

Comparison of ^sup 99m^Tc-3PRGD^sub 2^ Imaging and ^sup 18^F-FDG PET/CT in Breast Cancer and Expression of Integrin α^sub v^β^sub 3^ in Breast Cancer Vascular Endothelial Cells

The Journal of nuclear medicine (1978), 2018-05, Vol.59, p.488

2018

Volltextzugriff (PDF)

68Ga-FAPI and 18F-FDG PET/CT Images of a Patient With Rosai-Dorfman Disease With Liver Involvement

Clinical nuclear medicine, 2022-12, Vol.47 (12), p.1079

2022

Volltextzugriff (PDF)

Clinical value of [18F]F-FDG PET/CT in patients with suspected paraneoplastic dermatoses: Diagnostic performance and impact on clinical management

European journal of radiology, 2023-12, Vol.169, p.111170-111170, Article 111170

2023

Volltextzugriff (PDF)

Reference values of mandibular condylar growth activity: a study of SUVmax with quantitative bone SPECT/CT

Nuclear medicine communications, 2022-02, Vol.43 (2), p.152

2022

Volltextzugriff (PDF)

68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study

The Journal of nuclear medicine (1978), 2023-12, Vol.64 (12), p.1899-1905

2023

Volltextzugriff (PDF)

[ 99m Tc]3PRGD 2 for integrin receptor imaging of esophageal cancer: a comparative study with [ 18 F]FDG PET/CT

Annals of nuclear medicine, 2019-02, Vol.33 (2), p.135

2019

Volltextzugriff (PDF)

68 Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study

Journal of Nuclear Medicine, 2023-12, Vol.64 (12), p.1899-1905

2023

Volltextzugriff (PDF)

[68Ga]Pentixafor PET/CT for staging and prognostic assessment of newly diagnosed multiple myeloma: comparison to [18F]FDG PET/CT

European journal of nuclear medicine and molecular imaging, 2024-06, Vol.51 (7), p.1926-1936

2024

Volltextzugriff (PDF)

A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer

European journal of nuclear medicine and molecular imaging, 2024-02, Vol.51 (3), p.871-882

2024

Volltextzugriff (PDF)

A head-to-head comparison of [ 68 Ga]Ga-DOTATATE and [ 68 Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study

European journal of nuclear medicine and molecular imaging, 2024-05

2024

Volltextzugriff (PDF)

Correction to: A head-to-head comparison of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study

European journal of nuclear medicine and molecular imaging, 2024-06

2024

Volltextzugriff (PDF)

[68Ga]Ga‑LNC1007 PET/CT in the evaluation of renal cell carcinoma: comparison with 2-[18F]FDG/[68Ga]Ga-PSMA PET/CT

European journal of nuclear medicine and molecular imaging, 2024, Vol.51 (2), p.535-547

2024

Volltextzugriff (PDF)

Widespread Skin Infiltration of Leukemia Cutis on 18F-FDG PET/CT

Clinical nuclear medicine, 2020-11, Vol.45 (11), p.e489

2020

Volltextzugriff (PDF)

68Ga-FAPI Versus 18F-FDG PET/CT in Evaluating Newly Diagnosed Breast Cancer Patients: A Head-to-Head Comparative Study

Clinical nuclear medicine, 2023-03, Vol.48 (3), p.e104

2023

Volltextzugriff (PDF)

Primary Pancreatic Lymphoma Masquerading as Carcinoma on 18 F-FDG PET/CT

Clinical nuclear medicine, 2023-09, Vol.48 (9), p.820

2023

Volltextzugriff (PDF)

Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [ 68 Ga]Ga-FAPI-RGD

Theranostics, 2022-01, Vol.12 (16), p.7180-7190

2022

Volltextzugriff (PDF)

99mTc-3PRGD2 for integrin receptor imaging of lung cancer: a multicenter study

The Journal of nuclear medicine (1978), 2012-05, Vol.53 (5), p.716-722

2012

Volltextzugriff (PDF)

Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer: The REALITY Randomized Clinical Trial

JAMA oncology, 2022-02, Vol.8 (2), p.242

2022

Volltextzugriff (PDF)

68 Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients

Annals of nuclear medicine, 2022-05

2022

Volltextzugriff (PDF)

Imaging and monitoring HER2 expression in breast cancer during trastuzumab therapy with a peptide probe 99mTc-HYNIC-H10F

European journal of nuclear medicine and molecular imaging, 2020-10, Vol.47 (11), p.2613-2623

2020

Volltextzugriff (PDF)

Apatinib versus placebo in patients with locally advanced or metastatic, radioactive iodine-refractory, differentiated thyroid cancer: Post hoc analyses from the REALITY randomized clinical trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.6095-6095

2022

Volltextzugriff (PDF)

Study of novel molecular probe 99mTc-3PRGD2 in the diagnosis of rheumatoid arthritis

Nuclear medicine communications, 2015-12, Vol.36 (12), p.1208-1214

2015

Volltextzugriff (PDF)

Clinical evaluation of a novel atlas-based PET/CT brain image segmentation and quantification method for epilepsy

Quantitative imaging in medicine and surgery, 2022-09, Vol.12 (9), p.4538-4548

2022

Volltextzugriff (PDF)

Atlas of PET/CT in Oncology - Volume 1: Brain, Head and Neck Cancers

Volltextzugriff (PDF)

26 – 50 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(90)

Publikationsform

Sprache

Englisch
(104)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(44)
Humans
(29)
Radiology, Nuclear Medicine & Medical Imaging
(22)
Nuclear Medicine
(19)
Imaging
(18)
Medicine
(18)
Medicine & Public Health
(18)
Computed Tomography
(17)
Radiology
(17)
Positron Emission Tomography
(16)
Tumors
(16)
Fluorodeoxyglucose F18
(15)
Metastases
(15)
Patients
(15)
Female
(13)
Lymph Nodes
(13)
Medical Imaging
(13)
Positron Emission Tomography Computed Tomography
(12)
Tomography
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

sup 99m^Tc-3PRGD^sub 2^ for Integrin Receptor Imaging of Esophageal Cancer, Compared Study with ^sup 18^F-FDG PET/CT

Comparison of ^sup 99m^Tc-3PRGD^sub 2^ Imaging and ^sup 18^F-FDG PET/CT in Breast Cancer and Expression of Integrin α^sub v^β^sub 3^ in Breast Cancer Vascular Endothelial Cells

68Ga-FAPI and 18F-FDG PET/CT Images of a Patient With Rosai-Dorfman Disease With Liver Involvement

Clinical value of [18F]F-FDG PET/CT in patients with suspected paraneoplastic dermatoses: Diagnostic performance and impact on clinical management

Reference values of mandibular condylar growth activity: a study of SUVmax with quantitative bone SPECT/CT

68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study

[ 99m Tc]3PRGD 2 for integrin receptor imaging of esophageal cancer: a comparative study with [ 18 F]FDG PET/CT

68 Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study

[68Ga]Pentixafor PET/CT for staging and prognostic assessment of newly diagnosed multiple myeloma: comparison to [18F]FDG PET/CT

A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer

A head-to-head comparison of [ 68 Ga]Ga-DOTATATE and [ 68 Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study

Correction to: A head-to-head comparison of [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI PET/CT in patients with nasopharyngeal carcinoma: a single-center, prospective study

[68Ga]Ga‑LNC1007 PET/CT in the evaluation of renal cell carcinoma: comparison with 2-[18F]FDG/[68Ga]Ga-PSMA PET/CT

Widespread Skin Infiltration of Leukemia Cutis on 18F-FDG PET/CT

68Ga-FAPI Versus 18F-FDG PET/CT in Evaluating Newly Diagnosed Breast Cancer Patients: A Head-to-Head Comparative Study

Primary Pancreatic Lymphoma Masquerading as Carcinoma on 18 F-FDG PET/CT

Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [ 68 Ga]Ga-FAPI-RGD

99mTc-3PRGD2 for integrin receptor imaging of lung cancer: a multicenter study

Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer: The REALITY Randomized Clinical Trial

68 Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients

Imaging and monitoring HER2 expression in breast cancer during trastuzumab therapy with a peptide probe 99mTc-HYNIC-H10F

Apatinib versus placebo in patients with locally advanced or metastatic, radioactive iodine-refractory, differentiated thyroid cancer: Post hoc analyses from the REALITY randomized clinical trial

Study of novel molecular probe 99mTc-3PRGD2 in the diagnosis of rheumatoid arthritis

Clinical evaluation of a novel atlas-based PET/CT brain image segmentation and quantification method for epilepsy

Atlas of PET/CT in Oncology - Volume 1: Brain, Head and Neck Cancers

Suchergebnisse filtern